Genetic and pharmacologic evidence that mTOR targeting outweighs mTORC1 Inhibition as an antimyeloma strategy

  1. Chen, X.
  2. Díaz-Rodríguez, E.
  3. Ocio, E.M.
  4. Paiva, B.
  5. Mortensen, D.S.
  6. Lopez-Girona, A.
  7. Chopra, R.
  8. Miguel, J.S.
  9. Pandiella, A.
Aldizkaria:
Molecular Cancer Therapeutics

ISSN: 1535-7163,  1538-8514

Argitalpen urtea: 2014

Alea: 13

Zenbakia: 2

Orrialdeak: 504-516

Mota: Artikulua

DOI: 10.1158/1535-7163.MCT-13-0022 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus